5323002022-04-012022-06-305323002022-04-012022-06-30in-bse-fin:OtherExpenses1Member5323002022-04-012022-06-30

ItemsThatWillNotBeReclassifiedToProfitAndLoss1

5323002022-04-012022-06-30

ItemsThatWillBeReclassifiedToProfitAndLoss1

iso4217:INRiso4217:INRxbrli:shares

532300

WOCKPHARMA

INE049B01025

Wockhardt Limited

Equity

2022-04-01

2023-03-31

2022-08-12

2022-08-04

INR

Crores

First quarter

Single segment

Pharmaceuticals

2022-08-12

14:15:00

2022-08-12

15:45:00

Not applicable

2022-04-01

2022-06-30

Unaudited

Consolidated

5950000000

570000000

6520000000

1400000000

1150000000

-280000000

1800000000

730000000

640000000

2040000000

7480000000

-960000000

40000000

-250000000

-210000000

-750000000

-200000000

-950000000

-670000000

-80000000

-940000000

-10000000

720000000

-4.64

Notes To consolidated Results:- 1. For Notes to Consolidated Results please refer the notes from the Statement of Consolidated Un-Audited Results for the quarter ended June 30, 2022 as attached which is submitted under Outcome of Board Meeting today. 2. EPS for the quarter ended June 30, 2022 is not annualised.

Other Expenses

2040000000

Items that will not be reclassified to Profit or Loss -(charge) / credit (consisting of re-measurement of net defined benefit (liability) / asset)

-60000000

-10000000

Items that will be reclassified to Profit or Loss - (charge)/ credit (Consisting of Exchange differences on translating the financial statements of foreign operations)

-150000000